Glaxo invests $50 million in biotech startups to develop new medicine

GlaxoSmithKline will invest $50 million in a $250 million venture to help early-stage biotechnology companies develop new medicines.

Read more:
Glaxo invests $50 million in biotech startups to develop new medicine

Leave a Reply